Sarepta Therapeutics, Inc. financial data

Symbol
SRPT on Nasdaq
Industry
Pharmaceutical Preparations
Location
215 First Street, Suite 415, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
AVI BIOPHARMA INC (to 7/12/2012), ANTIVIRALS INC (to 5/12/1998)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 400 % -14.4%
Quick Ratio 79.7 % +71.2%
Debt-to-equity 197 % -36.1%
Return On Equity 19.7 %
Return On Assets 6.62 %
Operating Margin 11.5 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97M shares +2.65%
Common Stock, Shares, Outstanding 96.9M shares +3.38%
Common Stock, Value, Issued 10K USD +11.1%
Weighted Average Number of Shares Outstanding, Basic 95.1M shares +2.9%
Weighted Average Number of Shares Outstanding, Diluted 108M shares +16.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.9B USD +53%
Revenue from Contract with Customer, Excluding Assessed Tax 1.79B USD +56.2%
Costs and Expenses 1.68B USD +11.4%
Operating Income (Loss) 218M USD +557%
Nonoperating Income (Expense) 42.7M USD -36.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 261M USD +325%
Income Tax Expense (Benefit) 25.5M USD +60.8%
Net Income (Loss) Attributable to Parent 235M USD +248%
Earnings Per Share, Basic 2.47 USD/shares +111%
Earnings Per Share, Diluted 2.34 USD/shares +97.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.1B USD +157%
Cash, Cash Equivalents, and Short-term Investments 1.69B USD -15.8%
Accounts Receivable, after Allowance for Credit Loss, Current 602M USD +50.4%
Inventory, Net 750M USD +132%
Other Assets, Current 90.5M USD +16.4%
Assets, Current 3.07B USD +19.2%
Property, Plant and Equipment, Net 340M USD +49.8%
Operating Lease, Right-of-Use Asset 148M USD +14.1%
Other Assets, Noncurrent 79.9M USD -41.6%
Assets 3.96B USD +21.4%
Accounts Payable, Current 214M USD +30%
Employee-related Liabilities, Current 91.1M USD +15.7%
Accrued Liabilities, Current 374M USD +18.6%
Contract with Customer, Liability, Current 130M USD +158%
Liabilities, Current 732M USD +11.9%
Contract with Customer, Liability, Noncurrent 325M USD -25.6%
Operating Lease, Liability, Noncurrent 192M USD +36.5%
Other Liabilities, Noncurrent 1.75M USD -41.7%
Liabilities 2.44B USD +1.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -218K USD -124%
Retained Earnings (Accumulated Deficit) -4.21B USD +5.29%
Stockholders' Equity Attributable to Parent 1.53B USD +77.8%
Liabilities and Equity 3.96B USD +21.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -242M USD -15.6%
Net Cash Provided by (Used in) Financing Activities 22.1M USD -78.3%
Net Cash Provided by (Used in) Investing Activities 219M USD +1651%
Common Stock, Shares Authorized 198M shares 0%
Common Stock, Shares, Issued 96.9M shares +3.38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.14M USD +98.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.12B USD +152%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.19M USD +2.35%
Deferred Tax Assets, Valuation Allowance 888M USD +0.53%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 923M USD +1.21%
Operating Lease, Liability 206M USD +29.6%
Payments to Acquire Property, Plant, and Equipment 32.4M USD +242%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 234M USD +232%
Lessee, Operating Lease, Liability, to be Paid 382M USD -4.11%
Property, Plant and Equipment, Gross 574M USD +37.4%
Operating Lease, Liability, Current 13.3M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 31.5M USD -8.55%
Lessee, Operating Lease, Liability, to be Paid, Year One 31.8M USD -5.81%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 177M USD -26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 31.6M USD +12.7%
Deferred Tax Assets, Operating Loss Carryforwards 67.6M USD -56.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3.33M shares 0%
Unrecognized Tax Benefits 66.5M USD +2.31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 32.3M USD +15.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 11.1M USD
Current Federal Tax Expense (Benefit) 4.18M USD
Amortization of Intangible Assets 2.41M USD +54.3%
Depreciation, Depletion and Amortization 8.74M USD -22.7%
Share-based Payment Arrangement, Expense 180M USD -3.68%
Interest Expense -18.4M USD +16.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%